Riskpilot← Back to searchSign inGet full accessredhot diagnostics AB
ABActiveOrg 5568617731Forskargatan 20 JResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20111 employees
Revenue 2024
SEK 963K
+32% vs 2023
EBITDA margin
-8.8%
-400% vs 2023
Equity ratio
36.1%
Financial strength
Net profit 2024
SEK -282K
-28% vs 2023
| Revenue | SEK 963K | +32% |
| EBITDA | SEK -85K | -400% |
| Net profit | SEK -282K | -28% |
| Total assets | SEK 1,7M | -12% |
| Equity | SEK 628K | -31% |
| Employees | 1 | — |
Legal name
redhot diagnostics AB
Org number
5568617731
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
19 augusti 2011
Share capital
SEK 89 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet skall vara att utveckla, producera och marknadsföra diagnostikprodukter samt att utöva därmed förenlig verksamhet.
Address
Forskargatan 20 J
Email
info@redhotdiagnostics.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 444 | 562 | 216 | 315 | 288 | 730 | 963 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −448 | 68 | −83 | 214 | 230 | 358 | 429 | 40 | −17 | −85 |
| Depreciation & amort. | −0 | −13 | −18 | −18 | −23 | −43 | −35 | −100 | −164 | −166 |
| EBIT | −448 | 55 | −101 | 196 | 207 | 315 | 394 | −60 | −181 | −251 |
| Net financials | −138 | −39 | −39 | −53 | −51 | −38 | −40 | −32 | −40 | −31 |
| Profit before tax | −586 | 16 | −140 | 144 | 156 | 277 | 354 | −92 | −221 | −282 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −586 | 16 | −140 | 144 | 156 | 277 | 354 | −92 | −221 | −282 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 714 | 998 | 925 | 1 226 | 1 160 | 1 286 | 1 542 | 2 074 | 1 981 | 1 742 |
| Equity | −480 | −108 | −249 | −161 | −5 | 273 | 627 | 690 | 909 | 628 |
| Long-term debt | 659 | 682 | 707 | 208 | 896 | 830 | 604 | 456 | 318 | 345 |
| Short-term debt | 535 | 424 | 467 | 1 178 | 269 | 184 | 311 | 928 | 754 | 770 |
| Total debt | 1 194 | 1 106 | 1 174 | 1 386 | 1 165 | 1 014 | 915 | 1 384 | 1 072 | 1 115 |
EBITDA margin
-8.8%
This company
15.8%
Market median
-156% vs market
20152024
Equity ratio
36.1%
This company
38.2%
Market median
+5% vs market
20152024
Return on equity
-44.9%
This company
18.4%
Market median
-344% vs market
20152024
Net profit margin
-29.3%
This company
8.1%
Market median
-462% vs market
20152024
Asset turnover
0.55×
This company
1.12×
Market median
-51% vs market
20152024
Debt / equity
1.77×
This company
0.62×
Market median
-185% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TL Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
redhot diagnostics AB 
Pethmark ABBoard members of redhot diagnostics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Lennart Busch | Chief Executive Officer | 0 companies |
| Björn Ingemarsson | Board of Directors | 0 companies |
| Peter Stefan Rehnmark | Board of Directors | 0 companies |
| Lars Håkan Randahl | Chairman | 0 companies |
| Sten Johan Rydén | Board of Directors | 0 companies |
| Sven Mikael Undeland | Board of Directors | 0 companies |